Clinicians - Global Initiative for Chronic Obstructive Lung Disease

The GOLD Report provides un-biased and up to date guidance for clinicians on all aspects of the management of patients with COPD, including:

• Diagnosis and Assessment
• Initial pharmacological and non-pharmacological management
• Follow-up pharmacological and non-pharmacological management
• Management of exacerbations
• Management of comorbidities

The Report is extensively referenced and clinicians can refer to the original publications when necessary.

This page, specifically for clinicians, provides links to:

• Background material produced by members of the GOLD Board of Directors and Science Committee which summarise discussions of the evidence that have contributed to the development of the GOLD Reports
• Advocacy materials, particularly regarding COPD in low and middle income countries (LMIC), including some produce with the Global Alliance Against Chronic Respiratory Diseases (GARD) and the Forum of International Respiratory Societies (FIRS)
• Clinical resources such as the template for remote consultations

Background References
Rodriguez-Roisin R, Rabe KF, Vestbo J, Vogelmeier C, Agusti A. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary: a brief history of time. Eur Respir J. 2017;50(1). Epub 2017/07/07.

Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, López Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD Science Committee Report 2019. Eur Respir J. 2019;53:1900164.

Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O'Donnell D, Papi A, Pavord I, Roche N, Rodriguez-Roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR. Current Controversies in Chronic Obstructive Pulmonary Disease: A Report from the GOLD Scientific Committee. Ann Am Thorac Soc. 2019;16:29-39.

Martinez FJ, Agusti A, Celli BR, Han MK, Allinson J, Bhatt SP, Calverley P, Chotirmall SH, Chowdhury B, Darken P, Da Silva CA, Donaldson G, Dorinsky P, Dransfield M, Faner R, Halpin DM, Jones P, Krishnan JA, Locantore N, Martinez FD, Mullerova H, Price D, Rabe KF, Reisner C, Singh D, Vestbo J, Vogelmeier CF, Wise RA, Tal-Singer R, Wedzicha JA. Treatment Trials in Pre-COPD and Young COPD: Time to Move Forward. Am J Respir Crit Care Med 2021 (accepted for publication).

Han MK, Agusti A, Celli B, Criner GJ, Halpin DMG, Roche N, Papi A, Stockley R, Wedzicha JW, Vogelmeier CF. From Gold 0 to Pre-COPD. Am J Respir Crit Care Med. 2021;203:414-423.

Mortimer K, Montes de Oca M, Salvi S, Balakrishnan K, Hadifled R, Ramirez A; Halpin DMG, Ozoh OB, Han M, Perez Padilla R; Kirenga BJ, Balmes J. Household air pollution and COPD: cause and effect or confounding by other aspects of poverty? Int J Tuberc Lung Dis 2022 (accepted for publication)

Forum of International Respiratory Societies. The global impact of respiratory disease. Third Edition. European Respiratory Society, 2021 https://www.firsnet.org/resources/publications

Advocacy & COPD in LMIC References
Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A. It is time for the world to take COPD seriously: a statement from the GOLD board of directors. Eur Respir J. 2019;54:1900914,

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A. The GOLD Summit on COPD in Low and Middle Income Countries. Int J Tuberc Lung Dis 2019;23(11):1131-1141.

To T, Viegi G, Cruz A, Taborda-Barata L, Asher M, Behera D, Bennoor K, Boulet L-P, Bousquet J, Camargos P Conceicao, C Gonzalez Diaz S, El-Sony A, Erhola M, Gaga M, Halpin D, Harding L, Maghlakelidze T, Masjedi M, Mohammad Y, Nunes E, Pigearias B, Sooronbaev T, Stelmach R, Tsiligianni I, LE L, Valiulis A, Wang Chen, Williams S, Yorgancioglu A. A Global Respiratory Perspective on the COVID-19 Pandemic: Commentary and Action Proposals. Eur Respir J. 2020;56:2001704.

Singh SJ, Halpin DMG, Salvi S, Kirenga BJ, Mortimer K. Exercise and pulmonary rehabilitation for people with chronic lung disease in LMICs: challenges and opportunities. Lancet Respir Med 2019;7(12):1002-1004.

Meghji J, Mortimer K, Agusti A, Allwood BW, Asher I, Bateman ED, Bissell K, Bolton CE, Bush A, Celli B, Chiang CY, Cruz AA, Dinh-Xuan AT, El Sony A, Fong KM, Fujiwara PI, Gaga M, Garcia-Marcos L, Halpin DMG, Hurst JR, Jayasooriya S, Kumar A, Lopez-Varela MV, Masekela R, Mbatchou Ngahane BH, Montes de Oca M, Pearce N, Reddel HK, Salvi S, Singh SJ, Varghese C, Vogelmeier CF, Walker P, Zar HJ, Marks GB. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet. 2021 Mar 6;397(10277):928-940.

Forum of International Respiratory Societies. The global impact of respiratory disease. Third Edition. European Respiratory Society, 2021 https://www.firsnet.org/resources/publications

COPD & COVID References
Halpin DMG, Gerard J. Criner GJ, Papi A, Singh D, Anzuetto A, Martinez FJ, Agusti AA, Vogelmeier CF. The 2020 GOLD Science Committee Report on COVID-19 & COPD Am J Respir Crit Care Med 2021;203:24–36.

Halpin DMG, Vogelmeier CF, Agusti AA COVID-19 and COPD: Lessons beyond the pandemic. Am J Physiol Lung Cell Mol Physiol 2021;321:L978–L982.

Clinical Resources
Guidance on remote COPD patient follow-up and template for consultations: Although initially developed for use during the COVID pandemic the guidance and template can be used in any circumstance when remote follow-up is undertaken.